The results showed that while recipients of gut microbiota from donors with metabolic syndrome had worsened insulin sensitivity, recipients of gut microbiota from RYGB donors showed trends of improvement in insulin sensitivity, although the improvement was statistically insignificant. The gene discussed is INS; the disease is metabolic syndrome.